{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:50Z","timestamp":1790745890388,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc) is a complex autoimmune disease characterized by fibrotic, inflammatory, and vascular dysfunction. Danger-associated molecular patterns (DAMPs)-mediated inflammasome activation has been reported to be involved in the pathogenesis of SSc. Cold-inducible RNA-binding protein (CIRP) is newly identified as a DAMP. Here we examined the clinical significance of serum levels of CIRP in 60 patients with SSc and 20 healthy control patients (HCs) using an enzyme-linked immunosorbent assay. Serum CIRP levels in diffuse cutaneous SSc (dcSSc) patients were significantly increased compared with limited cutaneous SSc (lcSSc) patients or HCs. When examining the relationship with SSc-specific parameters, serum CIRP levels with the presence of interstitial lung disease (ILD) were higher than those without ILD. In detail, serum CIRP levels correlated negatively with the percent predicted diffusing capacity for carbon monoxide and positively with levels of Krebs von den Lungen-6. In addition, elevated serum CIRP levels declined along with decreased SSc-ILD activity in patients who received immunosuppressive therapy. These results suggest that CIRP may play a role in the development of ILD in SSc. Moreover, CIRP could serve as a useful serological marker of SSc-ILD in terms of disease activity and therapeutic effects.<\/jats:p>","DOI":"10.1038\/s41598-023-32231-1","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T10:04:58Z","timestamp":1679997898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum cold-inducible RNA-binding protein levels as a potential biomarker for systemic sclerosis-associated interstitial lung disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Issei","family":"Omori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayakazu","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Sugimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Urano-Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okuto","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"32231_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/1346-8138.14153","volume":"45","author":"Y Asano","year":"2018","unstructured":"Asano, Y. Systemic sclerosis. J. Dermatol. 45, 128\u2013138 (2018).","journal-title":"J. Dermatol."},{"key":"32231_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall, A. J. et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis. 69, 1809\u20131815 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"32231_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.40815","volume":"71","author":"M Elhai","year":"2019","unstructured":"Elhai, M. et al. Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 71, 972\u2013982 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"32231_CR4","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/jid.2010.120","volume":"130","author":"N Aden","year":"2010","unstructured":"Aden, N. et al. Epithelial cells promote fibroblast activation via IL-1\u03b1 in systemic sclerosis. J. Investig. Dermatol. 130, 2191\u20132200 (2010).","journal-title":"J. Investig. Dermatol."},{"key":"32231_CR5","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/jid.2014.253","volume":"134","author":"J Nikitorowicz-Buniak","year":"2014","unstructured":"Nikitorowicz-Buniak, J., Shiwen, X., Denton, C. P., Abraham, D. & Stratton, R. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9. J. Investig. Dermatol. 134, 2693\u20132702 (2014).","journal-title":"J. Investig. Dermatol."},{"key":"32231_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1165\/rcmb.2013-0366TR","volume":"51","author":"CD Ellson","year":"2014","unstructured":"Ellson, C. D., Dunmore, R., Hogaboam, C. M., Sleeman, M. A. & Murray, L. A. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 51, 163\u2013168 (2014).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"32231_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/nm.3368","volume":"19","author":"X Qiang","year":"2013","unstructured":"Qiang, X. et al. Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis. Nat. Med. 19(11), 1489\u20131495 (2013).","journal-title":"Nat. Med."},{"key":"32231_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0378-1119(97)00530-1","volume":"204","author":"H Nishiyama","year":"1997","unstructured":"Nishiyama, H. et al. Cloning and characterization of human CIRP (cold-inducible RNA-binding protein) cDNA and chromosomal assignment of the gene. Gene 204, 115\u2013120 (1997).","journal-title":"Gene"},{"key":"32231_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/JLB.3MIR1118-443R","volume":"106","author":"M Aziz","year":"2019","unstructured":"Aziz, M., Brenner, M. & Wang, P. Extracellular CIRP (eCIRP) and inflammation. J. Leukoc. Biol. 106, 133\u2013146 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"32231_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4155\/fsoa-2017-0077","volume":"3","author":"P Zhong","year":"2017","unstructured":"Zhong, P. & Huang, H. Recent progress in the research of cold-inducible RNA-binding protein. Future Sci. OA 3, 246\u20132056 (2017).","journal-title":"Future Sci. OA"},{"key":"32231_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2022.2039183","author":"H Bazid","year":"2022","unstructured":"Bazid, H. et al. Expression of cold-inducible RNA binding protein in psoriasis. J. Immunoassay Immunochem. https:\/\/doi.org\/10.1080\/15321819.2022.2039183 (2022).","journal-title":"J. Immunoassay Immunochem."},{"key":"32231_CR12","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.chest.2021.06.067","volume":"160","author":"H Hozumi","year":"2021","unstructured":"Hozumi, H. et al. Clinical significance of cold-inducible RNA-binding protein in idiopathic pulmonary fibrosis. Chest 160, 2149\u20132157 (2021).","journal-title":"Chest"},{"key":"32231_CR13","first-page":"1112","volume":"31","author":"K Yanaba","year":"2004","unstructured":"Yanaba, K., Hasegawa, M., Takehara, K. & Sato, S. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J. Rheumatol. 31, 1112\u20131120 (2004).","journal-title":"J. Rheumatol."},{"key":"32231_CR14","doi-asserted-by":"publisher","first-page":"e0255493","DOI":"10.1371\/journal.pone.0255493","volume":"16","author":"Y Fujita","year":"2021","unstructured":"Fujita, Y. et al. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still\u2019s disease. PLoS ONE 16, e0255493 (2021).","journal-title":"PLoS ONE"},{"key":"32231_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/1756-185X.12892","volume":"21","author":"IS Yoo","year":"2018","unstructured":"Yoo, I. S. et al. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis. Int. J. Rheum. Dis. 21, 148\u2013154 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"32231_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1462","author":"DA Lujan","year":"2018","unstructured":"Lujan, D. A., Ochoa, J. L. & Hartley, R. S. Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip. Rev. RNA https:\/\/doi.org\/10.1002\/wrna.1462 (2018).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"32231_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","volume":"182","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya, S. et al. Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: A novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 182, 192 (2013).","journal-title":"Am. J. Pathol."},{"key":"32231_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.38901","volume":"67","author":"T Takahashi","year":"2015","unstructured":"Takahashi, T. et al. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheumatol. 67, 254\u2013265 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"32231_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi, H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 162, 1109\u20131114 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32231_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/rheumatology\/keaa322","volume":"60","author":"T Nawata","year":"2021","unstructured":"Nawata, T., Shirai, Y., Suzuki, M. & Kuwana, M. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease. Rheumatology 60, 250\u2013255 (2021).","journal-title":"Rheumatology"},{"key":"32231_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.21037\/jtd.2017.02.48","volume":"9","author":"H Yamakawa","year":"2017","unstructured":"Yamakawa, H. et al. Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease. J. Thorac. Dis. 9, 362 (2017).","journal-title":"J. Thorac. Dis."},{"key":"32231_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/1346-8138.12461","volume":"41","author":"H Sumida","year":"2014","unstructured":"Sumida, H. et al. Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus. J. Dermatol. 41, 418\u2013420 (2014).","journal-title":"J. Dermatol."},{"key":"32231_CR23","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3389\/fimmu.2018.02434","volume":"9","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya, S. et al. Pharmacological inhibition of tolllike receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis. Front. Immunol. 9, 2434 (2018).","journal-title":"Front. Immunol."},{"key":"32231_CR24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747\u20131755 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"32231_CR25","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy, E. C. et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15, 202\u2013205 (1988).","journal-title":"J. Rheumatol."},{"key":"32231_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/1346-8138.14162","volume":"45","author":"Y Asano","year":"2018","unstructured":"Asano, Y. et al. Diagnostic criteria, severity classification and guidelines of systemic sclerosis. J. Dermatol. 45, 633\u2013691 (2018).","journal-title":"J. Dermatol."},{"key":"32231_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1183\/09059180.00005512","volume":"22","author":"JJ Solomon","year":"2013","unstructured":"Solomon, J. J. et al. Scleroderma lung disease. Eur. Respir. Rev. 22, 6\u201319 (2013).","journal-title":"Eur. Respir. Rev."},{"key":"32231_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/1346-8138.14669","volume":"45","author":"H Sumida","year":"2018","unstructured":"Sumida, H. et al. Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study. J. Dermatol. 45, 1425\u20131433 (2018).","journal-title":"J. Dermatol."},{"key":"32231_CR29","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/acr.21968","volume":"65","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?. Arthritis Care Res. 65, 1375\u20131380 (2013).","journal-title":"Arthritis Care Res."},{"key":"32231_CR30","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements, P. et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol. 22, 1281\u20131285 (1995).","journal-title":"J. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32231-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32231-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32231-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T10:14:19Z","timestamp":1679998459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32231-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32231"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32231-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5017"}}